Nasacort 55 mikrog/ dose Norveška - norveški - Statens legemiddelverk

nasacort 55 mikrog/ dose

opella healthcare france sas - triamcinolonacetonid - nesespray, suspensjon - 55 mikrog/ dose

Pevisone 1 mg/ g / 10 mg/ g Norveška - norveški - Statens legemiddelverk

pevisone 1 mg/ g / 10 mg/ g

karo pharma ab (1) - triamcinolonacetonid / ekonazolnitrat - krem - 1 mg/ g / 10 mg/ g

Synalar 0.025 % Norveška - norveški - Statens legemiddelverk

synalar 0.025 %

bioglan ab - fluocinolonacetonid - gel - 0.025 %

Livicort 64 mikrog/ dose Norveška - norveški - Statens legemiddelverk

livicort 64 mikrog/ dose

mcneil sweden ab - budesonid - nesespray, suspensjon - 64 mikrog/ dose

Livicort 32 mikrog/ dose Norveška - norveški - Statens legemiddelverk

livicort 32 mikrog/ dose

mcneil sweden ab - budesonid - nesespray, suspensjon - 32 mikrog/ dose

Weifapenin 50 mg/ ml Norveška - norveški - Statens legemiddelverk

weifapenin 50 mg/ ml

viatris as - fenoksymetylpenicillinkalium - pulver til mikstur, oppløsning - 50 mg/ ml

Basiron AC 5 % Norveška - norveški - Statens legemiddelverk

basiron ac 5 %

galderma nordic ab - benzoylperoksid, vandig - gel - 5 %

Basiron AC 10 % Norveška - norveški - Statens legemiddelverk

basiron ac 10 %

galderma nordic ab - benzoylperoksid, vandig - gel - 10 %

Flunixin Biovet vet 50 mg/ ml Norveška - norveški - Statens legemiddelverk

flunixin biovet vet 50 mg/ ml

biovet aps - fluniksinmeglumin - injeksjonsvæske, oppløsning - 50 mg/ ml

Idefirix Europska Unija - norveški - EMA (European Medicines Agency)

idefirix

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - immunsuppressive - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.